Table 3.
Demographics, BAHA surgical indications, and BAHA usage time of the study sample.
| Gender - % (n) | |
|---|---|
| Male | 18.2 (4) |
| Female | 81.8 (18) |
| Age - years; mean ± SD | 53.0 ± 10.8 |
| Implant side - % (n) | |
| Right | 54.5 (12) |
| Left | 45.5 (10) |
| Sugical Indication - % (n) | |
| COM with insufficient hearing gain with conventional hearing aids | 31.8 (7) |
| COM with recurrent otorrhea | 54.6 (12) |
| SSD | 9.1 (2) |
| External ear malformations | 4.5 (1) |
| Audio Processor Type - % (n) | |
| Baha® 5 | 63.6 (14) |
| Baha® 5 Power | 27.3 (6) |
| Baha® 5 SuperPower | 9.1 (2) |
| Overall daily hours of percutaneous BAHA use – hours; median ± IQR | 9.9 ± 8.6 |
| COM with insufficient hearing gain with conventional hearing aids | 12.0 ± 10.1 |
| COM with recurrent otorrhea | 10.4 ± 3.9 |
| SSD | 4.3 ± 4.7 |
Legend: SD – Standard deviation; COM – Chronic otitis media; SSD – Single-sided deafness; IQR – Interquartile range.